{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:59:34Z","timestamp":1738130374787,"version":"3.33.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n            <jats:italic>Duranta erecta<\/jats:italic> Linn. belongs to the Verbenaceae family and is primarily found in subtropical, tropical, and temperate climates. The plant has been reported to contain a variety of phytoconstituents, including iridoid glycosides, flavonoids, flavonoid glycosides, alkaloids, phenolics, tannins, terpenoids, steroids, and saponins. In this investigation, a bioactivity-guided isolation was used to isolate cyclooxygenases (COXs) and lipoxygenase (LOX)-inhibiting compounds from the leaves of <jats:italic>Duranta erecta<\/jats:italic> Linn. Duranterectoside A (<jats:bold>1<\/jats:bold>), lamiide (<jats:bold>2<\/jats:bold>), and apigenin 4\u2019,7-dimethyl ether (<jats:bold>3<\/jats:bold>) were identified employing spectroscopic methods (including ESI-MS, <jats:sup>1<\/jats:sup>H-NMR, and <jats:sup>13<\/jats:sup>C-NMR), and by comparing with existing literature data. This is the first report of metabolitrs from <jats:italic>D. erecta<\/jats:italic> inhibiting both LOX and COX enzymes. Furthermore, the isolated compounds were analyzed using computerized virtual screening, which enabled the modelling ADME characteristics, molecular docking, and dynamics simulation. The results demonstrated that compound <jats:bold>1<\/jats:bold> had greater docking scores than the docked lead compounds. Overall, the data reported in this study add to our understanding of the pharmacological properties of the examined plant and Duranterectoside A (<jats:bold>1<\/jats:bold>) and pave the way for future research and investigation in inflammation and drug discovery.<\/jats:p>","DOI":"10.1186\/s12906-025-04764-7","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T10:05:01Z","timestamp":1738058701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioactivity-guided isolation and molecular modeling of the anti-inflammatory constituents from the leaves of Duranta erecta Linn."],"prefix":"10.1186","volume":"25","author":[{"given":"Marina","family":"Sobhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid N.","family":"Kirollos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh F.","family":"AbouZid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser S. M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riham A.","family":"El-Shiekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essam","family":"Abdel-Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"4764_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.fitote.2012.04.018","volume":"83","author":"KY Chan","year":"2012","unstructured":"Chan KY, Mohamad K, Ooi AJ, Imiyabir Z, Chung LY. Bioactivity-guided fractionation of the lipoxygenase and cyclooxygenase inhibiting constituents from Chisocheton Polyandrus Merr. Fitoterapia. 2012;83:961\u20137.","journal-title":"Fitoterapia"},{"key":"4764_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jplph.2005.11.006","volume":"163","author":"A Liavonchanka","year":"2006","unstructured":"Liavonchanka A, Feussner I. Lipoxygenases: occurrence, functions and catalysis. J Plant Physiol. 2006;163:348\u201357.","journal-title":"J Plant Physiol"},{"key":"4764_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/187152908786786250","volume":"8","author":"N Bunimov","year":"2008","unstructured":"Bunimov N, Laneuville O. Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis. Cardiovasc Haematol Disorders-Drug Targets (Formerly Curr Drug Targets-Cardiovascular Hematol Disorders). 2008;8:268\u201377.","journal-title":"Cardiovasc Haematol Disorders-Drug Targets (Formerly Curr Drug Targets-Cardiovascular Hematol Disorders)"},{"key":"4764_CR4","doi-asserted-by":"crossref","unstructured":"G\u0142uszko P, Bieli\u0144ska A. Non\u2013steroidal anti\u2013inflammatory drugs and the risk of cardiovascular diseases: are we going to see the revival of cyclooxygenase\u20132 selective inhibitors? Pol Arch Med Wewn . 2009;119(4):231\u20135.","DOI":"10.20452\/pamw.662"},{"key":"4764_CR5","volume-title":"Adverse drug reactions and drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs): adverse drug reactions to nonsteroidal anti","author":"R Nagi","year":"2021","unstructured":"Nagi R, Reddy SS, Rakesh N. Adverse drug reactions and drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs): adverse drug reactions to nonsteroidal anti. -inflammatory Agents: OrangeBooks Publication; 2021."},{"key":"4764_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jtcme.2020.03.007","volume":"11","author":"IG Eke","year":"2021","unstructured":"Eke IG, Okpara GC. Anti-hyperglycemic and anti-dyslipidemic activities of methanol ripe fruit extract of Duranta erecta L (Verbenaceae) in normoglycemic and hyperglycemic rats. J Traditional Complement Med. 2021;11:209.","journal-title":"J Traditional Complement Med"},{"key":"4764_CR7","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.jep.2022.115274","volume":"293","author":"M Srivastava","year":"2022","unstructured":"Srivastava M, Shanker K. Duranta erecta Linn: a critical review on phytochemistry, traditional uses, pharmacology, and toxicity from phytopharmaceutical perspective. J Ethnopharmacol. 2022;293:115274.","journal-title":"J Ethnopharmacol"},{"key":"4764_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/0973-7847.194042","volume":"10","author":"R Subsongsang","year":"2016","unstructured":"Subsongsang R, Jiraungkoorskul W. An updated review on phytochemical properties of golden dewdrop Duranta erecta. Pharmacogn Rev. 2016;10:115.","journal-title":"Pharmacogn Rev"},{"key":"4764_CR9","doi-asserted-by":"publisher","first-page":"118617","DOI":"10.1016\/j.jep.2024.118617","volume":"335","author":"DE Ali","year":"2024","unstructured":"Ali DE, El-Shiekh RA, El Sawy MA, Khalifa AA, Elblehi SS, Elsokkary NH, et al. In vivo anti-gastric ulcer activity of 7-O-methyl aromadendrin and sakuranetin via mitigating inflammatory and oxidative stress trails. J Ethnopharmacol. 2024;335:118617.","journal-title":"J Ethnopharmacol"},{"key":"4764_CR10","doi-asserted-by":"publisher","first-page":"119316","DOI":"10.1016\/j.indcrop.2024.119316","volume":"221","author":"RA El-Shiekh","year":"2024","unstructured":"El-Shiekh RA, Ali DE, Mandour AA, Meselhy MR. Essential oils of Plumeria alba L. and Plumeria rubra L. growing in Egypt: GC\/MS analysis, molecular dynamics and in-vitro anti-cholinesterase activity. Ind Crops Prod. 2024;221:119316.","journal-title":"Ind Crops Prod"},{"key":"4764_CR11","doi-asserted-by":"publisher","first-page":"19637","DOI":"10.1038\/s41598-024-68743-7","volume":"14","author":"RM Ibrahim","year":"2024","unstructured":"Ibrahim RM, Abdel-Baki PM, Mohamed OG, Al-Karmalawy AA, Tripathi A, El-Shiekh RA. Metabolites profiling, in-vitro and molecular docking studies of five legume seeds for Alzheimer\u2019s disease. Sci Rep. 2024;14:19637.","journal-title":"Sci Rep"},{"key":"4764_CR12","doi-asserted-by":"crossref","unstructured":"Abdel-Sattar E, Kutkat O, El\u2010Shiekh RA, El\u2010Ashrey MK, El Kerdawy AM. In Silico and in Vitro Screening of some pregnane glycosides isolated from certain Caralluma species as SARS\u2010COV\u20102 main protease inhibitors. Chem Biodivers. 2024;21(4):e202301786.","DOI":"10.1002\/cbdv.202301786"},{"key":"4764_CR13","doi-asserted-by":"crossref","unstructured":"Radi MH, El-Shiekh RA, Hegab AM, Henry SR, Avula B, Katragunta K et al. LC-QToF chemical profiling of Euphorbia grantii Oliv. and its potential to inhibit LPS-induced lung inflammation in rats via the NF-\u03baB, CY450P2E1, and P38 MAPK14 pathways. Inflammopharmacology. 2023;32(1):461\u201394.","DOI":"10.1007\/s10787-023-01298-7"},{"key":"4764_CR14","doi-asserted-by":"crossref","unstructured":"Rimon G, Sidhu RS, Lauver DA, Lee JY, Sharma NP, Yuan C et al. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proceedings of the National Academy of Sciences. 2010;107:28\u201333.","DOI":"10.1073\/pnas.0909765106"},{"key":"4764_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"RG Kurumbail","year":"1996","unstructured":"Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384:644\u20138.","journal-title":"Nature"},{"key":"4764_CR16","first-page":"415","volume":"12","author":"E Skrzypczak-Jankun","year":"2003","unstructured":"Skrzypczak-Jankun E, Zhou K, Jankun J. Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 \u00c5 reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead. Int J Mol Med. 2003;12:415\u201320.","journal-title":"Int J Mol Med"},{"key":"4764_CR17","doi-asserted-by":"publisher","first-page":"106729","DOI":"10.1016\/j.bioorg.2023.106729","volume":"139","author":"EM Azmy","year":"2023","unstructured":"Azmy EM, Hagras M, Ewida MA, Doghish AS, Khidr EG, El-Husseiny AA, et al. Development of pyrolo [2, 3-c] pyrazole, pyrolo [2, 3-d] pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: synthesis, biological evaluation and molecular dynamics investigations. Bioorg Chem. 2023;139:106729.","journal-title":"Bioorg Chem"},{"key":"4764_CR18","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1002\/fsn3.1553","volume":"8","author":"W Li","year":"2020","unstructured":"Li W, Zhu Hw C, Yj, Xiao H, He GYH, et al. Bioactivity-guided isolation of anti\u2010inflammatory components from Phyllanthus emblica. Food Sci Nutr. 2020;8:2670\u20139.","journal-title":"Food Sci Nutr"},{"key":"4764_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.phytol.2024.07.005","volume":"62","author":"E Abdel-Sattar","year":"2024","unstructured":"Abdel-Sattar E, El-Shiekh RA. Chemical composition and biological activities of genus Ochrosia: a mini review. Phytochem Lett. 2024;62:92\u2013111.","journal-title":"Phytochem Lett"},{"key":"4764_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12917-024-04128-2","volume":"20","author":"MM Ali","year":"2024","unstructured":"Ali MM, Al-Mokaddem AK, Abdel-Sattar E, El-Shiekh RA, Farag MM, Aljuaydi SH, et al. Enhanced wound healing potential of arabincoside B isolated from Caralluma Arabica in rat model; a possible dressing in veterinary practice. BMC Vet Res. 2024;20:282.","journal-title":"BMC Vet Res"},{"key":"4764_CR21","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00044-016-1677-9","volume":"25","author":"M Sobeh","year":"2016","unstructured":"Sobeh M, Mamadalieva NZ, Mohamed T, Krstin S, Youssef FS, Ashour ML, et al. Chemical profiling of Phlomis thapsoides (Lamiaceae) and in vitro testing of its biological activities. Med Chem Res. 2016;25:2304\u201315.","journal-title":"Med Chem Res"},{"key":"4764_CR22","unstructured":"Sobhy M, AbouZid SF, Kirollos FN, El-Shiekh RA, Abdel-Sattar E. Lamiide and Ipolamiide: A comprehensive review of their bioactive properties and therapeutic potential. Chem Biodivers. e202401069."},{"key":"4764_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0031-9422(95)00024-2","volume":"39","author":"Y Takeda","year":"1995","unstructured":"Takeda Y, Morimoto Y, Matsumoto T, Ogimi C, Hirata E, Takushi A, et al. Iridoid glucosides from the leaves and stems of Duranta erecta. Phytochemistry. 1995;39:829\u201333.","journal-title":"Phytochemistry"},{"key":"4764_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.53879\/id.49.10.p0030","volume":"49","author":"A Saraswathy","year":"2012","unstructured":"Saraswathy A, Vidhya B, Amala K. Apigenin-4\u2032, 7-dimethyl ether from Aquilaria agallocha roxb. Indian Drugs. 2012;49:30\u20132.","journal-title":"Indian Drugs"},{"key":"4764_CR25","doi-asserted-by":"crossref","unstructured":"Dinda B. Pharmacology and applications of naturally occurring iridoids. Springer; 2019.","DOI":"10.1007\/978-3-030-05575-2"},{"key":"4764_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0378-8741(02)00181-2","volume":"82","author":"RH Delaporte","year":"2002","unstructured":"Delaporte RH, S\u00e1nchez GMn, Cuellar AC, Giuliani A, de Mello JCP. Anti-inflammatory activity and lipid peroxidation inhibition of iridoid lamiide isolated from Bouchea fluminensis (Vell.) Mold.(Verbenaceae). J Ethnopharmacol. 2002;82:127\u201330.","journal-title":"J Ethnopharmacol"},{"key":"4764_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/14786419.2015.1046870","volume":"30","author":"C Furusawa","year":"2016","unstructured":"Furusawa C, Yasuda S, Tsuji H, Ito S, Miyashita H, Yoshimitsu H, et al. A new triterpenoid glycoside from the leaves and stems of Duranta repens. Nat Prod Res. 2016;30:246\u201350.","journal-title":"Nat Prod Res"},{"key":"4764_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bioorg.2018.10.008","volume":"83","author":"A Ghith","year":"2019","unstructured":"Ghith A, Youssef KM, Ismail NS, Abouzid KA. Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents. Bioorg Chem. 2019;83:111\u201328.","journal-title":"Bioorg Chem"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04764-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04764-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04764-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:53:40Z","timestamp":1738101220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04764-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04764-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}